HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Relative efficacy of steroid therapy in immune thrombocytopenia mediated by anti-platelet GPIIbIIIa versus GPIbα antibodies.

Abstract
Immune thrombocytopenia (ITP) is characterized by platelet clearance mediated primarily by autoantibodies against the platelet GPIIbIIIa and/or GPIbα. Steroid therapy is a first-line treatment for ITP. However, some patients are refractory to this therapy and currently no method can predict which patients will respond. To evaluate whether steroids are equally efficacious in treating patients with ITP caused by anti-GPIIbIIIa versus anti-GPIbα antibodies, we performed a retrospective study on 176 newly diagnosed patients with acute ITP who had severe bleeding symptoms and were admitted as resident patients to the hospital. The patients were treated first with intravenous administration of high-dose dexamethasone (DXM), followed by oral administration of prednisone. Response to therapy was observed in a majority of patients with antibodies specific for GPIIbIIIa (31/43) or without detectable antibodies against either GPIIbIIIa or GPIbα (36/45). In contrast, the steroid response was significantly lower in patients with anti-GPIbα antibodies (9/34) or with antibodies against both GPIbα and GPIIbIIIa (16/54). The preliminary findings of this study suggest that in future prospective clinical trials including corticosteroids, the anti-GPIbα, and -GPIIbIIIa status should be assessed in order to test its potential relevance in deciding future treatments.
AuthorsQingshu Zeng, Lingyan Zhu, Lili Tao, Jing Bao, Mingzhen Yang, Elisa K Simpson, Conglei Li, Dianne E van der Wal, Pingguo Chen, Christopher M Spring, Mingli Wang, Lingjie Zhang, Changgeng Ruan, Ming Hou, Ruixiang Xia, Heyu Ni
JournalAmerican journal of hematology (Am J Hematol) Vol. 87 Issue 2 Pg. 206-8 (Feb 2012) ISSN: 1096-8652 [Electronic] United States
PMID22139961 (Publication Type: Journal Article)
CopyrightCopyright © 2011 Wiley Periodicals, Inc.
Chemical References
  • Autoantibodies
  • Glucocorticoids
  • Membrane Glycoproteins
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • Platelet Glycoprotein GPIb-IX Complex
  • adhesion receptor
  • Dexamethasone
  • Prednisone
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Autoantibodies (immunology)
  • Blood Platelets (drug effects, immunology, pathology)
  • Dexamethasone (pharmacology, therapeutic use)
  • Drug Administration Schedule
  • Drug Monitoring
  • Female
  • Glucocorticoids (pharmacology, therapeutic use)
  • Humans
  • Male
  • Membrane Glycoproteins (immunology)
  • Middle Aged
  • Platelet Glycoprotein GPIIb-IIIa Complex (immunology)
  • Platelet Glycoprotein GPIb-IX Complex
  • Prednisone (pharmacology, therapeutic use)
  • Purpura, Thrombocytopenic, Idiopathic (drug therapy, immunology, pathology)
  • Retrospective Studies
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: